Neonatal Neurological Examination to Detect Infants at Risk

Launched by FONDAZIONE POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI IRCCS · Mar 6, 2023

Keywords

ClinConnect Summary

This clinical trial is studying a special neurological examination designed to find early signs of brain problems in newborns who might be at risk. The goal is to see how effective this structured examination is in detecting these issues in infants, particularly those with neonatal encephalopathy, which is a condition that affects the brain and can happen in newborns.

The trial is looking for participants who are newborns up to 7 days old and either have neonatal encephalopathy or are considered at risk, such as premature infants born before 34 weeks or those who have had seizures. Families interested in participating will need to provide consent. If you choose to take part, you can expect to have your baby undergo this examination, which will help researchers learn more about the best ways to spot and address potential neurological problems early on.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • all newborns with neonatal encephaolopathy or at risk for neurological abnormlaities, such as preterm infants born below 34 weeks or those with convusions
• Exclusion Criteria:
• • families unwilling to sign consent